U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H6O3
Molecular Weight 162.1421
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 4-HYDROXYCOUMARIN

SMILES

OC1=CC(=O)OC2=C1C=CC=C2

InChI

InChIKey=VXIXUWQIVKSKSA-UHFFFAOYSA-N
InChI=1S/C9H6O3/c10-7-5-9(11)12-8-4-2-1-3-6(7)8/h1-5,10H

HIDE SMILES / InChI

Molecular Formula C9H6O3
Molecular Weight 162.1421
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Synthesis and biological evaluation of coumarin derivatives as inhibitors of Mycobacterium bovis (BCG).
2012-12
3-Acetyl-4-hy-droxy-6,7-dimethyl-2H-chromen-2-one.
2010-11-13
Molecular Basis for Drug Resistance in HIV-1 Protease.
2010-11
Synthesis of functionalized chromenes from Meldrum's acid, 4-hydroxycoumarin, and ketones or aldehydes.
2010-11
Warfarin: an environment-dependent switchable molecular probe.
2010-10-30
Regulators of the proteasome pathway, Uch37 and Rpn13, play distinct roles in mouse development.
2010-10-27
Structure-activity relationships of new 4-hydroxy bis-coumarins as radical scavengers and chain-breaking antioxidants.
2010-09
2,2,4-Trimethyl-7-nitro-2,3-dihydro-1H-1,5-benzodiazepin-5-ium perchlorate.
2010-06-26
Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology.
2010-06-13
Design of novel 4-hydroxy-chromene-2-one derivatives as antimicrobial agents.
2010-06-11
Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives.
2010-05-15
Inhibition of human DHODH by 4-hydroxycoumarins, fenamic acids, and N-(alkylcarbonyl)anthranilic acids identified by structure-guided fragment selection.
2010-04-06
Antimetastatic, antineoplastic, and toxic effects of 4-hydroxycoumarin in a preclinical mouse melanoma model.
2010-04
Ultrasound-assisted one-pot, three-component synthesis of spiro[indoline-3,4'-pyrazolo[3,4-b]pyridine]-2,6'(1'H)-diones in water.
2010-02
A novel 4-hydroxycoumarin biosynthetic pathway.
2010-01
Synthesis of 3-amino-4-hydroxy coumarin and dihydroxy-phenyl coumarins as novel anticoagulants.
2010
(4R)-Ethyl 4-(4-chloro-phen-yl)-2-hydr-oxy-5-oxo-2,3,4,5-tetra-hydro-pyrano[3,2-c]chromene-2-carboxyl-ate.
2009-12-19
Synthesis and insecticidal activity of new 4-hydroxy-2H-1-benzopyran-2-one derivatives.
2009-12
Synthesis and biological evaluation of coumarin-based inhibitors of NAD(P)H: quinone oxidoreductase-1 (NQO1).
2009-11-26
4,4-Dimethyl-2-tosyl-1,2,3,3a,4,11b-hexa-hydro-11H-pyrrolo[3,4-c]pyrano[5,6-c]chromen-11-one 0.125-hydrate.
2009-10-31
Diastereoselective synthesis of trans-2,3-dihydrofurans with pyridinium ylide assisted tandem reaction.
2009-10-02
Formation of coumarines during the degradation of alkyl substituted aromatic oil components by the yeast Trichosporon asahii.
2009-10
HPLC method for simultaneous determination of impurities and degradation products in zonisamide.
2009-09
Study on the inhibitory mechanism and binding mode of the hydroxycoumarin compound NSC158393 to HIV-1 integrase by molecular modeling.
2009-09
Ethyl 2-hydr-oxy-5-oxo-4-phenyl-2,3,4,5-tetra-hydro-pyrano[3,2-c]chromene-2-carboxyl-ate.
2009-07-25
Investigation of the antioxidant properties of some new 4-hydroxycoumarin derivatives.
2009-07
4-Hydr-oxy-3-[(2E)-3-(3,4,5-trimethoxy-phen-yl)prop-2-eno-yl]-2H-chromen-2-one.
2009-06-20
Synthesis and studies of new 2-(coumarin-4-yloxy)-4,6-(substituted)-S-triazine derivatives as potential anti-HIV agents.
2009-05
Reactions of 3-benzoyl-7-dimethylamino-4-hydroxycoumarin and their potential applications in solution- and solid-phase synthesis.
2009-05
Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatography.
2009-04-17
Synthesis and molecular descriptor characterization of novel 4-hydroxy-chromene-2-one derivatives as antimicrobial agents.
2009-04-14
Redox active donor-substituted punicin derivatives.
2009-04-07
3-Anilinothio-carbonyl-4-hydroxy-chromen-2-one.
2009-03-31
Design and microwave-assisted synthesis of naphtho[2,3-f]quinoline derivatives and their luminescent properties.
2009-03-09
Biosynthesis of biphenyls and benzophenones--evolution of benzoic acid-specific type III polyketide synthases in plants.
2009-03-02
Systems pharmacology and genome medicine: a future perspective.
2009-01-22
Pharmacogenomics of anticoagulants: steps toward personal dosage.
2009-01-21
Electrochemical synthesis of 4-(dihydroxyphenylthio)-2H-chromen-2-one derivatives.
2008-11
Coumarin, anthroquinone and stilbene derivatives with anticholinesterase activity.
2008-08-02
The synthesis and antimicrobial activity of some 4-hydroxycoumarin derivatives.
2008-08
Synthesis and antimicrobial evaluation of some novel 2-aminothiazole derivatives of 4-hydroxy-chromene-2-one.
2008-08
2-Amino-4'-bromo-2',5-dioxo-4H,5H-pyrano[3,2-c]chromene-4-spiro-3'(2'H)-1'H-indole-3-carbonitrile N,N-dimethyl-formamide solvate.
2008-05-30
3D-QSAR investigation of synthetic antioxidant chromone derivatives by molecular field analysis.
2008-03
Comparison of the effect of 4-hydroxycoumarin and umbelliferone on the phase transition of dipalmitoylphosphatidylcholine (DPPC) bilayers.
2007-06-22
Antifungal and antibacterial activities of Mexican tarragon (Tagetes lucida).
2006-05-17
Biotin-avidin amplified enzyme-linked immunosorbent assay for determination of isoflavone daidzein.
2005-02-15
Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications.
1997-12
Coumarin-based inhibitors of HIV integrase.
1997-01-17
Competitive inhibition of HIV-1 protease by 4-hydroxy-benzopyran-2-ones and by 4-hydroxy-6-phenylpyran-2-ones.
1994-05-16
Inhibitory effect of coumarins on HIV-1 replication and cell-mediated or cell-free viral transmission.
1993-08
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:39:02 GMT 2025
Edited
by admin
on Mon Mar 31 19:39:02 GMT 2025
Record UNII
X954ZLL2RD
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
4-HYDROXYCOUMARIN
Systematic Name English
NSC-11889
Preferred Name English
4-HYDROXYCHROMEN-2-ONE
Systematic Name English
2H-1-BENZOPYRAN-2-ONE, 4-HYDROXY-
Systematic Name English
4-HYDROXYCOUMARIN [USP IMPURITY]
Common Name English
4-HYDROXY-2H-1-BENZOPYRAN-2-ONE
Systematic Name English
BENZOTETRONIC ACID
Common Name English
WARFARIN SODIUM IMPURITY B [EP IMPURITY]
Common Name English
4-COUMARINOL
Systematic Name English
COUMARIN, 4-HYDROXY-
Systematic Name English
Code System Code Type Description
ECHA (EC/EINECS)
214-060-2
Created by admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
PRIMARY
PUBCHEM
54682930
Created by admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
PRIMARY
NSC
11889
Created by admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
PRIMARY
WIKIPEDIA
4-Hydroxycoumarin
Created by admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
PRIMARY
CHEBI
40070
Created by admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
PRIMARY
CHEBI
77858
Created by admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
PRIMARY
FDA UNII
X954ZLL2RD
Created by admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
PRIMARY
EPA CompTox
DTXSID8061472
Created by admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
PRIMARY
CAS
1076-38-6
Created by admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
PRIMARY
DRUG BANK
DB03410
Created by admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
PRIMARY
MESH
C068805
Created by admin on Mon Mar 31 19:39:02 GMT 2025 , Edited by admin on Mon Mar 31 19:39:02 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
PARENT -> IMPURITY
correction factors: for the calculation of content, multiply the peak areas of the following impurity by the corresponding correction factor: impurity B = 0.5
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP